COVID-19 Outcome Prediction and Monitoring Solution for Military Hospitals in South Korea: Development and Evaluation of an Application by 박유랑
Original Paper
COVID-19 Outcome Prediction and Monitoring Solution for Military
Hospitals in South Korea: Development and Evaluation of an
Application
JoonNyung Heo1*, MD; Ji Ae Park2*, MS; Deokjae Han3, MD; Hyung-Jun Kim3, MD; Daeun Ahn4, BS; Beomman
Ha1, MD, PhD; Woong Seog1, MD; Yu Rang Park2, PhD
1Armed Forces Medical Command, Seongnam, Republic of Korea
2Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea
3Department of Internal Medicine, The Armed Forces Capitol Hospital, Seongnam, Republic of Korea
4Department of Nursing, The Armed Forces Capitol Hospital, Seongnam, Republic of Korea
*these authors contributed equally
Corresponding Author:
Yu Rang Park, PhD
Department of Biomedical Systems Informatics




Phone: 82 2 2228 2493
Email: yurangpark@yuhs.ac
Abstract
Background: COVID-19 has officially been declared as a pandemic, and the spread of the virus is placing sustained demands
on public health systems. There are speculations that the COVID-19 mortality differences between regions are due to the disparities
in the availability of medical resources. Therefore, the selection of patients for diagnosis and treatment is essential in this situation.
Military personnel are especially at risk for infectious diseases; thus, patient selection with an evidence-based prognostic model
is critical for them.
Objective: This study aims to assess the usability of a novel platform used in the military hospitals in Korea to gather data and
deploy patient selection solutions for COVID-19.
Methods: The platform’s structure was developed to provide users with prediction results and to use the data to enhance the
prediction models. Two applications were developed: a patient’s application and a physician’s application. The primary outcome
was requiring an oxygen supplement. The outcome prediction model was developed with patients from four centers. A Cox
proportional hazards model was developed. The outcome of the model for the patient’s application was the length of time from
the date of hospitalization to the date of the first oxygen supplement use. The demographic characteristics, past history, patient
symptoms, social history, and body temperature were considered as risk factors. A usability study with the Post-Study System
Usability Questionnaire (PSSUQ) was conducted on the physician’s application on 50 physicians.
Results: The patient’s application and physician’s application were deployed on the web for wider availability. A total of 246
patients from four centers were used to develop the outcome prediction model. A small percentage (n=18, 7.32%) of the patients
needed professional care. The variables included in the developed prediction model were age; body temperature; predisease
physical status; history of cardiovascular disease; hypertension; visit to a region with an outbreak; and symptoms of chills,
feverishness, dyspnea, and lethargy. The overall C statistic was 0.963 (95% CI 0.936-0.99), and the time-dependent area under
the receiver operating characteristic curve ranged from 0.976 at day 3 to 0.979 at day 9. The usability of the physician’s application
was good, with an overall average of the responses to the PSSUQ being 2.2 (SD 1.1).
Conclusions: The platform introduced in this study enables evidence-based patient selection in an effortless and timely manner,
which is critical in the military. With a well-designed user experience and an accurate prediction model, this platform may help
save lives and contain the spread of the novel virus, COVID-19.
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Introduction
COVID-19, which is caused by the SARS-CoV-2 virus, has
officially been declared a pandemic [1]. Despite the effort, there
were still casualties caused by the disease. The mortality rate
of the disease varies between countries and even between cities
in China [2]. There are speculations that these mortality rate
discrepancies between regions are due to the availability of
medical resources in that area. For instance, the mortality rate
difference between the city of Hubei and other provinces is
significant (~3% for Hubei and 0.7% for the rest of China), and
plotting the cases per population against mortality rates shows
a positive correlation [2].
The spread of the virus is currently placing sustained demands
on public health systems [3]. At present, there is an imbalance
in the supply and demand of medical supplies, and many efforts
are being made to solve this problem [4]. Although it is ideal
if the increase in medical supplies could meet the high demand,
this seems to be difficult for many underdeveloped countries.
Adjusting demand, such as by selecting the patients for diagnosis
and treatment, can also be an option considering that the rates
for severe cases are relatively low, with severe cases at 14%
and critical cases at 5% based on Chinese reports [5].
Comparably, rates of the asymptomatic cases are surprisingly
high, with some reporting up to 75% [6-8]. In this context, the
Centers for Disease Control and Prevention (CDC) recommends
that not all patients be hospitalized, considering the insufficient
medical infrastructure. However, there is no definite guideline
regarding patient selection due to insufficient evidence on which
patients need professional care.
Military personnel are especially at risk, since the viral spread
is the most critical in settings where people are living closely
in groups [9,10]. The adenovirus infection is one of the examples
of an infectious disease that is easily spread in the military.
Additionally, soldiers are frequently relocated worldwide, which
may accelerate the spread of the disease. For instance, in 2007,
basic military trainees were infected with the adenovirus and
were sent to multiple sites throughout the world, causing an
outbreak in those military bases [9].
The confusion, urea, respiratory rate, blood pressure, and 65
years or older (CURB-65) score is a widely known scoring
system for predicting the outcome of patients with pneumonia
[11]. The presence of confusion, blood urea nitrogen, respiratory
rate, systolic and diastolic blood pressure, and age are assessed
to calculate a score ranging from 0 to 6, with 6 indicating the
highest severity. The American Thoracic Society guidelines
suggest that patients with CURB-65 scores of less than 2 are at
a low risk of death and may be managed as outpatients. In
response to the outbreak, this score was used for patients with
COVID-19 [12]. However, even though patients with higher
CURB-65 scores were more likely to be severe, more than 20%
of the patients with lower scores also had poor outcomes,
suggesting the need for a new system to guide patient selection.
Previous studies have developed prognostic models to predict
mortality risk, hospital stay, and progression to severe state
[13-21]. The largest sample size of these studies was 577
patients from China [19]. Ideally, prediction models should be
based on a large data set covering multiple nations and races
for vast adaptation. Four of these studies presented models (eg,
decision tree, nomogram, and scoring rule) that could be used
in clinical practice [14,16,17,21].
When a prediction model is being developed and deployed in
the real world, multiple factors should be considered. As
previously stated, the included samples should be from multiple
centers across multiple nations to account for disparities between
races. Additionally, the model should provide a practical and
irreplaceable value to its users. The objective of the model
should be clear and should be able to answer a major question
in the clinical field. The model’s ease of use should also be
considered. However, these requirements are difficult—if not
impossible—to meet in a situation where a novel infection is
spreading worldwide.
In this study, we present a platform that provides outcome
prediction and status monitoring for patients with COVID-19
that is consistently enhanced with data collected based on the
use of the model.
Methods
Development of the Platform Structure
The platform structure was designed to primarily serve the users
by providing the results of the prediction models and sending
the results to the appointed physician. The data sent by the user
to acquire the results were collected by the server with the user’s
consent. The newly collected data was used for training the
models to further enhance its predictability and generalizability,
thereby completing the virtuous cycle. There are two
applications employed to serve this purpose: (1) a patient’s
application and (2) a physician’s application.
The main functionality of the patient’s application is to provide
outcome prediction results to the patient with their general
information, previously diagnosed diseases, symptoms, and
body temperature. Specifically, the purpose of the outcome
prediction is to guide patient selection for medical resource
allocation. Thus, the main target of the prediction model is to
determine whether the patient will need professional care.
The application receives the variables that the patient provides
to acquire the prediction results, sends them to the central server,
and shares them with the appointed physician for remote
monitoring. When the patient visits a health care facility, the
patient can pair their application with the physician’s application
to keep the physician notified of the change in the patient’s
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symptoms without needing any direct contact. The physician’s
application then receives a registration code that can be created
from the patient’s application. Upon registering a patient, the
health care worker can receive all the records and prediction
results from the patient’s application. This process is depicted
in Figure 1.
Figure 1. Diagram of the whole structure of the platform.
Three physicians reviewed previous publications related to
COVID-19 to select the appropriate variables for collection
[22-24]. On the basis that this novel virus might have similar
features to the pre-existing viruses that cause viral pneumonia,
the characteristics of other viral pneumonias were also
considered. The selection result was then reviewed by two
physicians who are currently directly involved with treating
patients with COVID-19 (Multimedia Appendix 1).
Participants and Data Collection for Outcome
Prediction
All patients with COVID-19 admitted to four centers (two
military hospitals and two civilian hospitals) in Korea were
included in the study. A total of 246 patients were included,
and data collection ran from February 6, 2020, to April 2, 2020.
There were no exclusion criteria.
The candidate risk factors for the patient’s application included
patient demographic characteristics (age, gender, and BMI),
past history (asthma, chemotherapy, chronic kidney disease,
hypertension, chronic obstructive pulmonary disease,
immunosuppressant use, cardiovascular disease, chronic liver
disease, and diabetes), patient symptoms (anosmia, rhinorrhea,
chest pain, phlegm, chills, physical status, cough, pneumonia,
diarrhea, pneumonia, antipyretic, dyspnea, feverish, headache,
muscle pain, nausea or vomiting, tired or lethargy, and sore
throat), social history (visit to a region with an outbreak, direct
contact with a patient with COVID-19, smoking history,
household member confirmed with COVID-19, and household
member under self-isolation), and body temperature during
hospitalization.
The outcome measured in this study was the use of an oxygen
supplement monitored up to April 6, 2020—the final date of
follow-up. The length of time (days) from the date of
hospitalization to the date of first use of an oxygen supplement
was considered as our target outcome. Oxygen supplement was
chosen as the outcome measure since it may be able to represent
the minimal treatment required for hospital admission.
Statistical Analysis
Descriptive statistics were obtained for all study variables.
Continuous data were expressed as mean (SD) values, and
categorical data were expressed as proportions.
A survival curve for overall patients was plotted using the
Kaplan-Meier method. Using all candidate risk factors, we
conducted a univariate analysis by a Cox proportional hazards
model to select factors. The factors with P<.05 were included
in the final model. The body temperature collected during
hospitalization was used as the time-dependent variable in the
Cox proportion hazards model [25]. By generating time intervals
during the day after the date of hospitalization, the average body
temperature recorded at each time interval (day) was calculated.
That is, the body temperature was considered as a value that
changed every day. In case of missing body temperature, the
last observation carried forward approach was used. A
multivariate Cox proportional hazard model (with
time-dependent variables) using selected factors was considered
as the prediction model for the patient’s application. The
multicollinearity between the factors included in the final model
was confirmed through variance inflation factors (VIFs), which
quantify the severity of multicollinearity in an ordinary least
squares regression analysis. We considered that VIF of 5 or
above indicates a multicollinearity problem [26]. Also,
additionally, association between factors was examined through
phi coefficient between two binary factors, point-biserial
correlation between a continuous and a binary factor, and
pearson correlation between two continuous factors. To calculate
VIF through the ordinary least square regression analysis and
J Med Internet Res 2020 | vol. 22 | iss. 11 | e22131 | p. 3https://www.jmir.org/2020/11/e22131
(page number not for citation purposes)
Heo et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
to measure correlation between factors, the median body
temperature during hospitalization was considered for body
temperature with time-varying characteristics.
We calculated the Harrell C statistic to assess the overall
predictive accuracy and time-dependent area under the receiver
operating characteristic curve (area under the curve [AUC])
[27] to assess the predictive accuracy over the entire follow-up
period. The AUC results of the Cox model, which vary
depending on the time point to be evaluated, were summarized
by days. We also performed the likelihood ratio, Wald, and
score tests to measure overall goodness of fit based on the
omnibus test of model coefficients. The chi-square
goodness-of-fit test proposed by Schoenfeld [28] was used for
the proportional hazards. Since body temperature was considered
as a time-varying variable updated every day in the model, we
did not check the assumption for body temperature. A random
subsampling [29] was used to estimate the internal validity of
the final Cox proportional hazards model, with 50 repeated
samplings dividing the train and test sets into 2:1. The sampling
was performed by stratifying according to the occurrence of the
outcome event to establish balance in the test and train sets. An
average time-dependent AUC based on the 50 repetitions was
used as a result of the validation.
The Cox proportional hazards model was considered as a
prediction model for the patient’s application, but we
additionally constructed a logistic model as an alternative model
by using selected factors from the final Cox model. The logistic
model was designed to predict oxygen supplement use during
hospitalization.
All P values were two-sided, and P<.05 was considered
statistically significant. Statistical analysis was performed using
R 3.6.0 (R Foundation for Statistical Computing) [29].
Evaluation of the Physician’s Application
A usability study was conducted to evaluate the usability of the
health care worker’s application wherein participants had to be
medical doctors with more than 1 year of clinical practice. A
total of 50 physicians were recruited from a public website, and
there was no exclusion or selection of the participants. The
participants were introduced to the entire platform and briefed
about its objectives. After a thorough explanation of the study,
a consent form was signed by the participants. They were then
instructed to sign up for the service through the physician’s
application and then add a prepared sample patient case that
was provided. Afterward, participants were required to complete
several tasks: review the symptoms that the sample case reported
through the patient’s application, review the results from the
outcome prediction model of the registered patient, and add
additional factitious clinical variables for the patient from the
variable input form. The result from the model was presented
as the probability of requiring an oxygen supplement, expressed
as a number between 0%-100%. The participants were educated
on the intended clinical utility of the result from the prediction
model to provide supportive information that can be used during
patient selection. However, the usefulness of the prediction
model could not be assessed since the data were not from a real
patient. The participants were instructed to fill the factitious
values of the patients’ clinical variables required by the
physician’s input form. The study protocol was approved by
the institutional review board at the Yonsei University College
of Medicine (4-2020-0351).
Following the completion of the tasks, the Post-Study System
Usability Questionnaire (PSSUQ) was used to acquire the
participants’ responses [30]. The results from the PSSUQ were




The platform consists of three parts: (1) the patient’s application,
(2) the physician’s application, and (3) the model application
programming interface. Both the patient’s and the physician’s
applications are deployed on the web. The web platform was
chosen to be able to enable instant modification upon
deployment and maximize the availability on variable devices.
Considering the majority of devices the users will be using, the
patient’s application is configured to be best viewed on a mobile
device and the physician’s application on a desktop. The
diagram of the entire structure is illustrated in Figure 2.
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Figure 2. Screenshots showing how patient recorded data is shown in the physician’s app to monitor the patient’s status.
This platform is registered in the World Health Organization
Digital Atlas for COVID-19 solutions [31].
Real-World Use of the Platform
A patient is advised to use the patient’s application when they
are officially diagnosed with COVID-19. They are also advised
to use the application every day and provide information about
their daily symptoms and body temperature. If the result from
the application shows a high likelihood of requiring
hospitalization and the patient is not currently admitted to a
hospital, then the patient is advised to contact a nearby health
care professional. If there is a previously appointed physician
monitoring the patient’s daily symptoms, then the physician
can check the daily status of the patient. Using the results of
the application, the physician is then able to make a proper
clinical decision about whether the patient will need
hospitalization. The result that the physician receives is the raw
probability calculated from the prediction model. No cut-off
was set, since the cut-off will be affected by environmental
factors, such as the availability of hospital beds or the regional
number of confirmed patients.
Development of the Outcome Prediction Model
The baseline characteristics of all 246 patients are shown in
Multimedia Appendix 2. The mean (SD) of age (year) and BMI
(kg/m2) were 40.72 (SD 17.10) years and 3.21 (SD 3.28) kg/m2,
respectively. A total of 167 (67.89%) patients were male. The
mean (SD) of the max and median body temperature during
follow-up were 37.32 °C (SD 0.56) and 36.75 °C (SD 0.42),
respectively. The most common symptom was coughing (95
patients, 41.13%), and 192 (83.12%) patients visited a region
with a COVID-19 outbreak.
One patient with missing date of hospitalization among 246
patients was excluded to estimate the survival rate for oxygen
supplement. During 2469.32 person-days of follow-up, oxygen
supplement was observed in 18 (7.35%) patients. The median
(IQR) time from hospitalization to censoring was 17.64 (IQR
14.24-21.70) days. The Kaplan-Meier estimates of the 3-day
and 5-day survival rate were 0.947 (95% CI 0.919-0.975) and
0.930 (95% CI 0.898-0.963), respectively.
Table 1 shows results of the univariate and multivariate Cox
proportional hazards models. In the univariate analysis, 10 of
the candidate risk factors showed results of P<.05 (Table 1). It
was confirmed that hypertension (hazard ratio [HR] 3.792, 95%
CI 1.423-10.109), cardiovascular disease (HR 12.413, 95% CI
4.069-37.869), predisease physical status (HR 1.854, 95% CI
1.24-2.773), dyspnea (HR 13.498, 95% CI 4.527-40.252),
feeling feverish (HR 6.282, 95% CI 2.054-19.213), chills (HR
5.727, 95% CI 1.924-17.048), tiredness or lethargy (HR 6.083,
95% CI 1.989-18.607), older age (HR 1.075, 95% CI
1.052-1.098), and higher body temperature (HR 13.147, 95%
CI 6.849-25.237) were risk factors for earlier oxygen
supplement, while visiting a region with an outbreak (HR 0.291,
95% CI 0.095-0.89) was confirmed as a risk factor that
decreased the risk of oxygen supplement.
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Table 1. Hazard ratio of univariate and multivariate Cox proportional hazards model.
Multivariate modelbUnivariate model, HRa (95% CI)Factors
P valueHR (95% CI)
.471.035 (0.983-1.089)1.075 (1.052-1.098)Age (years)
.0117.431 (2.856-106.371)13.147 (6.849-25.237)Body temperatureb (°C)
.810.562 (0.033-9.437)3.793 (1.423-10.109)Hypertension (yes)
.490.217 (0.008-6.111)12.413 (4.069-37.869)CVDc (yes)
.283.381 (0.133-86.084)0.291 (0.095-0.89)Visit to a region of outbreak (yes)
.0074.259 (1.679-10.802)1.854 (1.24-2.773)Physical status
.433.878 (0.454-33.111)13.498 (4.527-40.252)Dyspnea (yes)
.260.321 (0.05-2.073)6.282 (2.054-19.213)Feverish (yes)
.950.905 (0.049-16.705)5.727 (1.924-17.048)Chills (yes)
.621.506 (0.174-13.019)6.083 (1.989-18.607)Tired/lethargic (yes)
aHR: hazard ratio.
bCox proportional hazards model with time-dependent variable.
cCVD: cardiovascular disease.
As a result of multivariate analysis including all 10 factors,
body temperature (HR 17.431, 95% CI 2.856-106.371) was
found to be the most powerful risk factor for oxygen supplement.
Physical status remained statistically significant as a factor
(P=.007), while the other eight factors were not statistically
significant.
The proportional hazards assumption on the factors included in
the multivariate model (except for body temperature, since it is
considered as a time-varying variable) was checked. Results
showed that all factors satisfied the assumption (Multimedia
Appendix 3). The multicollinearity and association between the
factors included in the multivariate model were not detected
(Multimedia Appendices 4 and 5).
To confirm the effects of body temperature in the multivariate
model, we considered a case for a fully active man 40 years of
age without any past history or symptoms and compared survival
rates according to body temperature (Figure 3). In cases of
temperatures of 37 °C, 38 °C, 38.5 °C, and 39 °C, the 5-day
survival rates were 0.994 (95% CI 0.9810-1), 0.906 (95% CI
0.7071-1), 0.663 (95% CI 0.1782-1), and 0.180 (95% CI
0.0002-1), respectively. At 39 °C, the 5-day survival rate rapidly
decreased.
Figure 3. Survival rate according to body temperature in predictive model present in the patient’s application. The 5-day survival rates for each initial
body temperature are shown.
For the multivariate model, the overall C statistic was 0.963
(95% CI 0.936-0.99), and the time-dependent AUC ranged from
0.976 at day 3 to 0.979 at day 9 (Figure 4). Multimedia
Appendix 6 shows the time-dependent AUC ranging from day
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1 to day 10. The value for each day was above 0.96. The AUC
of 8 days or more were the same because the outcome event did
not occur after 7.25 days.
Figure 4. Time-dependent area under the receiver operating characteristic curve at 3, 6, and 9 days from the prediction model present in the patient’s
application.
As per the result of internal validation for estimating the
performance and validity of the multivariate Cox proportional
hazards model in Table 1, the average time-dependent AUC
ranging from day 1 to day 10 showed a range from a minimum
of 0.749 to a maximum of 0.764 (Multimedia Appendix 7).
The results from the model are displayed at the result section
of the application when the user has completed a series of
questionnaires. The results page shows the 7day survival result
based on the received variables.
As results of the multivariate logistic model, body temperature
(odds ratio [OR] 19.106, 95% CI 1.587-229.961), physical status
(OR 5.145, 95% CI 1.539-17.205), and age (OR 1.099, 95% CI
1.028-1.174) were statistically associated with oxygen
supplementation during hospitalization (Multimedia Appendix
8). The P values of the likelihood ratio and score tests were less
than .001, and the Hosmer and Lemeshow test showed a P value
of .99. In addition, the AUC was 0.973 (95% CI 0.9413-1;
Multimedia Appendix 9).
Platform Evaluation
The usability study was performed with 50 participants from
May 1, 2020, to May 31, 2020. Participants had a mean age of
35.9 years, and 35 (70.0%) were men. All participants were
able to complete the given tasks easily. The detailed results are
shown in Table 2. The participants were instructed to answer
the PSSUQ on a scale of 1-7, with “1” being the most agreeable
to the statement. The lower the values of the answers, the better
the user experience was. Overall, the participants were satisfied
with the app, with the overall average of the responses being
2.2 (SD 1.1). The most disagreeable statement from the
questionnaire was the seventh statement (“The system gave
error messages that clearly told me how to fix problems”), which
had a mean response of 2.7. However, no error was experienced
during the study process, thus many of the participants chose
“4” as a response, which stood for “neutral.”
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Table 2. Usability study results (score ranging from 1 to 7, one being “strongly agree”).
Score, mean (SD)Statements
2.0 (1.0)1. Overall, I am satisfied with how easy it is to use this system.
2.0 (1.1)2. It was simple to use this system.
2.2 (1.1)3. I was able to complete the tasks and scenarios quickly using this system.
2.2 (1.2)4. I felt comfortable using this system.
2.0 (1.1)5. It was easy to learn to use this system.
2.0 (1.1)6. I believe I could become productive quickly using this system.
2.7 (1.3)7. The system gave error messages that clearly told me how to fix problems.
2.3 (1.2)8. Whenever I made a mistake using the system, I could recover easily and quickly.
2.0 (1.0)9. The information such as online help, on-screen messages, and other documentation provided with this system was clear.
2.3 (1.2)10. It was easy to find the information I needed.
2.1 (1.1)11. The information was effective in helping me complete the tasks and scenarios.
2.0 (1.1)12. The organization of information on the system screens was clear.
2.1 (1.2)13. The interface of this system was pleasant.
2.1 (1.2)14. I liked using the interface of this system.
2.4 (1.2)15. This system has all the functions and capabilities I expect it to have.
2.1 (1.0)16. Overall, I am satisfied with this system.
Discussion
Principal Findings
In this study, we developed a platform to provide the users with
the most up to date, evidence-based prediction model that can
guide them in making decisions on whether to seek professional
care or hospitalization, using only the variables provided by the
users. The result provided to the users is the probability of the
patient requiring oxygen supplement. With this, patients can
effectively and accurately monitor themselves on whether they
will need hospitalization during self-quarantine. Physicians can
use the result from the prediction model for patient selection
for hospitalization and risk assessment when needed. The
platform collects the data required to calculate the prediction
results and uses the data to update the prediction results given
directly to the users. The developed Cox model in this study
has a high accuracy with an AUC of 0.97 or higher. Our model
showed that body temperature was the most important factor
for oxygen supplement. A usability study was performed with
PSSUQ, which showed that the participants were generally
satisfied with the application.
Timely Patient Selection and the Military
The platform is currently used in military hospitals in Korea.
Collection of data and deployment of the outcome prediction
model is essential in military settings. If a soldier were to be
confirmed with the disease, an exceptionally large number of
people would be at risk. In contrast, the patients are likely to
be considered low risk, that is, having low probability of
requiring professional care, since most of them will be younger
and healthier than the general population. This special
circumstance, where an explosive spread of the virus is expected
but only a few will need special care, will pose a greater
importance in the selection of patients for both diagnosis and
treatment. A large fraction of the confirmed patients will not
be hospitalized, so a close and efficient method for monitoring
these patients is necessary. However, the platform was
developed considering its use outside of the military when
needed. Therefore, patients from two public hospitals were
included in the study to address this possibility.
The platform is tailored to fit needs in situations like the
COVID-19 pandemic, where data of the novel disease is scarce,
and the disease is spreading so fast that traditional clinical trials
are not timely enough. Clinical trials are carefully designed to
minimize bias and clearly prove a hypothesis. Accuracy and
reliability are critical in the medical field, but progressive
measures may be required during desperate times. Furthermore,
real-world data may be more representative of the patient
populations in the clinical field [32]. However, the results
derived from this platform should be used in a complementary
manner, especially if there is more reliable evidence such as a
randomized controlled trial.
The main goal of this platform is to provide the physician with
a supportive measure to assess the patient’s risk of requiring
professional care. The probability of the patient requiring
admission is provided to the physician in the form of a
percentage (ie, 0%-100%). The model does not decide if the
patient will need hospitalization but provides the risk
information of the patient to the physician so a proper decision
can be made. Considering the availability of medical resources
and the number of patients confirmed with COVID-19, the
physician will have to decide which patient will require
hospitalization. The prediction model is expected to help the
physician with complementary information for the better
prioritization of patients.
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Evaluation of the Outcome Prediction Model
The model presented in our study used 246 patients’ data from
four centers in Korea to predict whether a patient would need
hospitalization during the course of the disease. The Cox
proportional hazards ratio model was used to account for the
time-dependent variable (ie, body temperature), and the model
showed a high predictive accuracy (C statistic: 0.963; AUC at
9 days: 0.979). Ten features were selected in the model: age,
body temperature, history of hypertension, cardiovascular
disease, visit to a region with an outbreak, predisease physical
status, dyspnea, feeling feverish, chills, and tiredness or lethargy.
Body temperature showed the highest HR (17.431, 95% CI
2.856-106.371), followed by predisease physical status (HR
4.259, 95% CI 1.679-10.802) and dyspnea (HR 3.898, 95% CI
0.454-33.111; Table 1).
The predictors selected for the model are mostly consistent with
previous reports. Although age and comorbidities are already
well-established risk factors for grave outcomes [33,34], dyspnea
was also found to be associated with disease progression [33].
In our study, the effect of body temperature was the most
important predictor. For example, a patient who is a fully active
man 40 years of age without any past history or symptoms was
highly likely to need an oxygen supplement within 5 days with
a 5-day survival rate of 0.18 at 39 °C (Figure 3). Abnormal body
temperature is a well-known risk factor for grave prognosis in
patients with community-acquired pneumonia [35]. Physical
status, which is often expressed in the activities of daily living
score, is known to be an independent risk factor for mortality
among older adult patients with pneumonia [36,37].
When multivariable prediction models are developed, the
number of outcome events compared to the number of
predictors, referred to as the events per variable (EPV), affects
the accuracy of the model. In general, it is known that a reliable
sample size is at least 10 events per predictor (variable) in
logistic and Cox models [38,39]. In our model, this rule is not
satisfied for the 10 predictors included in the final model. The
problem of this low EPV was affected by the accuracy and
precision of the coefficients. In addition to the sample size, there
is also a possibility that the standard error of the coefficient was
overestimated due to the multicollinearity [40], and as a result
of the VIF, there was no multicollinearity between predictors
(Multimedia Appendix 10). Since overfitting most notably
occurs when the number of candidate predictors is large relative
to the number of outcome events [41], our model could also be
an overfitted model. For this reason, the AUC in the total
development sample was about 0.97 (Figure 4), but the result
in the internal validation was about 0.75 (Multimedia Appendix
7).
Caution should be employed in the interpretation of several risk
factors’ HR in the developed Cox model. We constructed the
multivariate Cox model by selecting only statistically significant
variables from the univariate model. In the univariate model,
the HRs of all risk factors were calculated in the expected
direction for outcome risk. However, in the multivariate model,
hypertension, cardiovascular disease, feeling feverish, and visits
to a region with an outbreak were calculated in a different
direction from the result in the univariate model. As these factors
have a relatively weak influence compared to body temperature
and physical status, and the statistical significance disappeared,
caution should be taken in the interpretation of the estimated
HRs in contrast to the univariate model.
In the developed Cox proportional hazards model, it is accurate
to define the onset of follow-up as the date when the patient
was infected with COVID-19. However, it was difficult to
accurately estimate the date of infection. Therefore, the onset
of follow-up was defined as the date of hospitalization or the
date on which the patient first recorded data in the application.
The inability to accurately estimate the period between the date
when the patient was infected with COVID-19 and the date
considered as the onset of follow-up can be considered as a
limitation of the model.
Usability of the Physician’s Application
Usability evaluation was performed for the physician’s
application since the use of the application should be effortless
to lessen their overwhelming workload due to the COVID-19
pandemic. Additionally, the application will be used in the
setting where a physician must monitor a large number of
patients; therefore, the usability will have a major impact. The
application is simple, presenting a list of associated patients on
the first page and showing details of the patient when clicking
on the list. Consequently, the use questionnaire showed
promising results, with a mean score of the total PSSUQ being
2.2 (SD 1.1). The time taken to complete the given tasks was
not recorded, but many participants had completed the tasks
under 10 minutes and were surprised by how simple the tasks
were. The most disagreeable question was the seventh question,
which inquired whether the error message was easy to
understand for the user. Since no participant experienced an
error, the result from the question was unreliable.
Other Applications and Outcome Prediction Models
for COVID-19
Although not evidence-based, there are some applications that
help patients by providing behavioral guidance when they
suspect COVID-19 infection. Our initially developed
applications, CheckUp Classic and Triage Classic, provided
expert opinion-based guidelines in patient selection for testing
and patient triage, respectively. These applications received
more than 240,000 visits worldwide in a month. Additionally,
Apple Inc published a COVID-19 Screening Tool in cooperation
with the CDC [42]. A self-triage and self-scheduling tool were
also developed based on a well-designed algorithm. This tool
is designed to be tethered to the electronic medical records [43].
A few models have been developed to predict the outcome for
patients with COVID-19, and a systemic review has been
performed [44]. In the review, the authors conclude that all of
these models are not useful in the clinical setting. This is
primarily due to poor adherence to guidelines and small data
size, both of which are unavoidable in a situation where there
is not enough time. In a recent editorial, the author emphasizes
the importance of sharing data to overcome the limitations of
building such a prediction model [45]. However, motive for the
researchers to share the hard-earned patient data is weak. Data
collection is an additional burden for the already occupied health
J Med Internet Res 2020 | vol. 22 | iss. 11 | e22131 | p. 9https://www.jmir.org/2020/11/e22131
(page number not for citation purposes)
Heo et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
care providers. There are a few efforts to collect nationwide or
worldwide data for patients with COVID-19 [46,47].
COVID-19 Estimated Risk (COVER) was one of the models
developed using the common data model [48]. The model
comprises nine variables: age, sex, history of cancer, chronic
obstructive pulmonary disease, diabetes, heart disease,
hypertension, hyperlipidemia, and kidney disease. It was
developed based on 6,869,127 patients with influenza or flu-like
symptoms. Although the score itself was not originally
developed for patients with COVID-19, it was validated with
43,061 patients with COVID-19. The performance, measured
with the AUC, was 0.73-0.81 for COVER-H (predicting
hospitalization), 0.73-0.91 for COVER-I (predicting intensive
care), and 0.82-0.90 for COVER-F (predicting fatality).
Future Research
Regardless of the accuracy or the representativeness of the data
set used for the development of the prediction model, the clinical
utility of the platform should be prospectively evaluated.
Whether additional information from the prediction model is
helpful for the physician or if it is redundant should be further
studied. Considering that outcome may vary according to
environmental factors, it is questionable if a single prediction
model could be generalized worldwide or if there should be
separate models for each environment. Currently the platform
is not considered for evaluation as an authorized medical device.
Extensive prospective research following collection of large
data sets to fully represent the target population should be
performed.
Limitations
There are limitations in this study. First, the design of the study
does not conform to any previous guidelines for clinical studies.
This is due to the difference of scope and objective between
traditional clinical studies and this platform. Even so, this study
is prone to many types of bias, so the results from this study
should be handled with care. Auditing of data is not possible
since there is no direct contact with the users, so the
completeness or accuracy of the data cannot be ensured. The
platform itself is unique, so the study design has never been
validated. Considering that the guideline for patient
hospitalization is dependent on multiple factors including
hospital capacity, governmental guidelines, and patient risk, a
single outcome measure cannot be used. Thus, the primary
outcome measure—oxygen supplement—is not a definite marker
for hospital admission. However, for our data set, all cases were
reviewed, and there was no patient that needed hospitalization
without receiving oxygen supplement.
Our prediction model was developed from a multicenter data
set. However, the model was constructed based on a small data
set of a single ethnicity, which can cause selection bias. In
addition, since the model has not been built with sufficient data
size, there may be a problem in terms of the model’s accuracy.
With more data acquisition, we will reinforce our model to
expand the population applied to the model and increase the
generalizable possibilities by performing external validation
for other patients.
Conclusion
The platform introduced in this study provides evidence-based
decision support to guide patient selection in an effortless and
timely manner, which is critical in the military. With a
well-designed user experience and an accurate prediction model,
this platform may help save lives and contain the spread of the
novel virus, COVID-19.
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